Aurora Cannabis (ACB) Stock Forecast, Price Target & Predictions
ACB Stock Forecast
Aurora Cannabis stock forecast is as follows: an average price target of $5.92 (represents a 2.07% upside from ACB’s last price of $5.80) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.
ACB Price Target
The average price target for Aurora Cannabis (ACB) is $5.92 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $8.75 to $1.00. This represents a potential 2.07% upside from ACB's last price of $5.80.
ACB Analyst Ratings
According to 7 Wall Street analysts, Aurora Cannabis's rating consensus is 'Hold'. The analyst rating breakdown for ACB stock is 0 'Strong Buy' (0.00%), 2 'Buy' (28.57%), 5 'Hold' (71.43%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Aurora Cannabis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 11, 2023 | EBITDA Q3 | Piper Sandler | $1.00 | $0.88 | 14.06% | -82.76% |
| May 28, 2021 | Heather Balsky | Bank of America Securities | $8.75 | $9.66 | -9.39% | 50.92% |
| May 14, 2021 | Tamy Chen | BMO Capital | $8.00 | $6.86 | 16.62% | 37.93% |
The latest Aurora Cannabis stock forecast, released on Jan 11, 2023 by EBITDA Q3 from Piper Sandler, set a price target of $1.00, which represents a 14.06% increase from the stock price at the time of the forecast ($0.88), and a -82.76% decrease from ACB last price ($5.80).
Aurora Cannabis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $5.80 | $5.80 | $5.80 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Aurora Cannabis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aurora Cannabis's last price of $5.80. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Feb 16, 2024 | Canaccord Genuity | Hold | Positive | Upgrade |
| Sep 21, 2022 | Canaccord Genuity | - | Hold | Downgrade |
| Sep 21, 2022 | Maxim Group | - | Hold | Downgrade |
| Sep 21, 2022 | Needham | - | Hold | Initialise |
| Sep 21, 2022 | Exane BNP Paribas | - | Outperform | Initialise |
| Sep 21, 2022 | Wolfe Research | - | Peer Perform | Initialise |
| Sep 21, 2022 | Barclays | - | Equal-Weight | Downgrade |
| Sep 21, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Jun 24, 2022 | Cantor Fitzgerald | - | Neutral | Upgrade |
Aurora Cannabis's last stock rating was published by Canaccord Genuity on Feb 16, 2024. The company Upgrade its ACB rating from "Hold" to "Positive".
Aurora Cannabis Financial Forecast
Aurora Cannabis Revenue Forecast
| Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $61.68M | $49.26M | $50.22M | $50.43M | $60.59M | $60.11M | $54.61M | $55.16M | $67.67M | $67.81M | $72.11M | $75.52M | $56.03M |
| Avg Forecast | $58.89M | $54.99M | $56.24M | $67.28M | $55.65M | $51.89M | $52.19M | $63.97M | $57.33M | $53.38M | $51.35M | $56.67M | $51.34M | $47.82M | $46.44M | $56.86M | $50.24M | $47.95M | $40.45M | $40.81M | $45.53M | $54.68M | $54.50M | $47.59M | $53.72M | $47.58M | $46.64M | $67.95M | $82.61M | $48.70M |
| High Forecast | $60.93M | $56.89M | $58.19M | $69.61M | $57.58M | $53.69M | $54.00M | $66.19M | $59.32M | $55.23M | $52.38M | $58.64M | $53.12M | $48.51M | $48.05M | $58.83M | $51.98M | $49.61M | $41.85M | $41.93M | $46.78M | $56.18M | $56.00M | $48.90M | $55.19M | $48.89M | $47.92M | $69.81M | $84.88M | $50.03M |
| Low Forecast | $56.83M | $53.07M | $54.28M | $64.93M | $53.71M | $50.08M | $50.37M | $61.73M | $55.33M | $51.52M | $50.32M | $54.70M | $49.55M | $47.29M | $44.82M | $54.88M | $48.48M | $46.28M | $39.04M | $39.69M | $44.28M | $53.18M | $53.01M | $46.28M | $52.24M | $46.28M | $45.36M | $66.08M | $80.34M | $47.36M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 3 | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 11 | 10 | 10 | 11 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.29% | 1.22% | 1.23% | 1.11% | 1.11% | 1.10% | 1.15% | 1.03% | 1.42% | 1.45% | 1.06% | 0.91% | 1.15% |
Aurora Cannabis's average Quarter revenue forecast for Mar 23 based on 0 analysts is $50.24M, with a low forecast of $48.48M, and a high forecast of $51.98M. ACB's average Quarter revenue forecast represents a -18.55% decrease compared to the company's last Quarter revenue of $61.68M (Dec 22).
Aurora Cannabis EBITDA Forecast
| Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 3 | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 11 | 10 | 10 | 11 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-53.87M | $-38.34M | $-61.90M | $-52.21M | $-33.60M | $27.84M | $-87.03M | $-132.22M | $-249.73M | $-66.45M | $-1.89B | $-112.98M | $-1.25B |
| Avg Forecast | $-35.73M | $-33.36M | $-34.12M | $-40.82M | $-33.76M | $-31.48M | $-31.66M | $-38.81M | $-34.78M | $-32.39M | $-31.15M | $-34.38M | $-31.15M | $-29.02M | $-28.17M | $-34.50M | $-30.48M | $-29.09M | $-24.54M | $-24.76M | $-19.16B | $-33.18M | $-33.07M | $-28.87M | $-233.98M | $-28.87M | $-28.30M | $-41.22M | $-94.97M | $-29.55M |
| High Forecast | $-34.48M | $-32.20M | $-32.93M | $-39.39M | $-32.58M | $-30.39M | $-30.56M | $-37.45M | $-33.57M | $-31.26M | $-30.53M | $-33.18M | $-30.06M | $-28.69M | $-27.19M | $-33.29M | $-29.42M | $-28.08M | $-23.69M | $-24.08M | $-15.33B | $-32.26M | $-32.16M | $-28.08M | $-187.19M | $-28.08M | $-27.52M | $-40.09M | $-75.97M | $-28.73M |
| Low Forecast | $-36.97M | $-34.52M | $-35.30M | $-42.23M | $-34.93M | $-32.58M | $-32.76M | $-40.15M | $-35.99M | $-33.51M | $-31.78M | $-35.58M | $-32.23M | $-29.43M | $-29.15M | $-35.69M | $-31.54M | $-30.10M | $-25.39M | $-25.44M | $-23.00B | $-34.09M | $-33.98M | $-29.66M | $-280.78M | $-29.66M | $-29.07M | $-42.36M | $-113.96M | $-30.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.85% | 1.56% | 2.50% | 0.00% | 1.01% | -0.84% | 3.01% | 0.57% | 8.65% | 2.35% | 45.76% | 1.19% | 42.48% |
0 analysts predict ACB's average Quarter EBITDA for Dec 21 to be $-33.18M, with a high of $-32.26M and a low of $-34.09M. This is -219.18% lower than Aurora Cannabis's previous annual EBITDA (Sep 21) of $27.84M.
Aurora Cannabis Net Income Forecast
| Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 3 | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 11 | 10 | 10 | 11 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-67.18M | $-51.89M | $-618.78M | $-1.01B | $-75.14M | $-11.88M | $-128.13M | $-164.65M | $-292.79M | $-108.06M | $-1.87B | $-137.40M | $-1.29B |
| Avg Forecast | $5.73M | $5.73M | $5.25M | $2.39M | $1.91M | $1.91M | $1.43M | $-1.91M | $-1.77M | $-4.15M | $-5.15M | $-8.21M | $-8.55M | $-6.37M | $-30.73M | $-24.65M | $-18.97M | $-122.21M | $-40.52M | $-60.45M | $-20.11B | $-117.91M | $-146.05M | $-183.46M | $-291.38M | $-352.53M | $-480.12M | $-308.54M | $-115.49M | $-275.80M |
| High Forecast | $5.99M | $5.99M | $5.49M | $2.49M | $2.00M | $2.00M | $1.50M | $-1.82M | $-1.69M | $-3.97M | $643.42K | $-7.84M | $-8.16M | $-6.08M | $-10.24M | $-23.53M | $-18.11M | $-116.67M | $-38.68M | $-58.29M | $-16.09B | $-113.70M | $-140.84M | $-176.91M | $-233.10M | $-339.95M | $-462.99M | $-297.53M | $-92.39M | $-265.96M |
| Low Forecast | $5.47M | $5.47M | $5.01M | $2.28M | $1.82M | $1.82M | $1.37M | $-2.00M | $-1.86M | $-4.34M | $-10.62M | $-8.58M | $-8.94M | $-6.66M | $-40.97M | $-25.76M | $-19.83M | $-127.73M | $-42.34M | $-62.61M | $-24.13B | $-122.12M | $-151.26M | $-190.00M | $-349.65M | $-365.11M | $-497.25M | $-319.55M | $-138.59M | $-285.64M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.55% | 1.28% | 10.24% | 0.05% | 0.64% | 0.08% | 0.70% | 0.57% | 0.83% | 0.23% | 6.07% | 1.19% | 4.66% |
Aurora Cannabis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ACB's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Aurora Cannabis SG&A Forecast
| Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 3 | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 11 | 10 | 10 | 11 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $44.57M | $45.04M | $50.36M | $43.17M | $46.86M | $48.61M | $48.82M | $46.92M | $47.96M | $51.19M | $41.36M | $89.35M | $119.84M |
| Avg Forecast | $50.56M | $47.21M | $48.29M | $57.77M | $47.78M | $44.56M | $44.81M | $54.92M | $49.22M | $45.83M | $44.09M | $48.66M | $44.08M | $41.06M | $39.87M | $48.82M | $43.13M | $41.17M | $34.73M | $35.04M | $39.09M | $46.95M | $46.80M | $40.86M | $46.12M | $40.86M | $40.05M | $58.34M | $75.11M | $41.81M |
| High Forecast | $52.31M | $48.85M | $49.96M | $59.77M | $49.44M | $46.10M | $46.36M | $56.83M | $50.93M | $47.42M | $44.98M | $50.35M | $45.61M | $41.65M | $41.26M | $50.51M | $44.63M | $42.60M | $35.94M | $36.00M | $40.16M | $48.24M | $48.08M | $41.98M | $47.39M | $41.98M | $41.14M | $59.94M | $90.13M | $42.96M |
| Low Forecast | $48.80M | $45.56M | $46.60M | $55.75M | $46.11M | $43.00M | $43.25M | $53.01M | $47.50M | $44.23M | $43.20M | $46.96M | $42.54M | $40.61M | $38.48M | $47.12M | $41.63M | $39.73M | $33.52M | $34.08M | $38.02M | $45.66M | $45.51M | $39.74M | $44.86M | $39.74M | $38.95M | $56.74M | $60.08M | $40.67M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.30% | 1.44% | 1.10% | 1.00% | 1.04% | 1.19% | 1.02% | 1.17% | 1.28% | 0.71% | 1.19% | 2.87% |
Aurora Cannabis's average Quarter SG&A projection for Mar 23 is $43.13M, based on 0 Wall Street analysts, with a range of $41.63M to $44.63M. The forecast indicates a -3.22% fall compared to ACB last annual SG&A of $44.57M (Dec 22).
Aurora Cannabis EPS Forecast
| Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 1 | 2 | 1 | 1 | 3 | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 11 | 10 | 10 | 11 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.21 | $-0.17 | $-2.88 | $-4.72 | $-0.38 | $-0.06 | $-0.65 | $-0.85 | $-1.74 | $-0.92 | $-15.94 | $-1.37 | $-14.16 |
| Avg Forecast | $0.12 | $0.12 | $0.11 | $0.05 | $0.04 | $0.04 | $0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.11 | $-0.17 | $-0.18 | $-0.13 | $-0.65 | $-0.52 | $-0.40 | $-2.58 | $-0.85 | $-1.27 | $-2.72 | $-2.49 | $-3.08 | $-3.87 | $-6.06 | $-7.43 | $-10.12 | $-6.51 | $-7.23 | $-5.82 |
| High Forecast | $0.13 | $0.13 | $0.12 | $0.05 | $0.04 | $0.04 | $0.03 | $-0.04 | $-0.04 | $-0.08 | $0.01 | $-0.17 | $-0.17 | $-0.13 | $-0.22 | $-0.50 | $-0.38 | $-2.46 | $-0.82 | $-1.23 | $-2.62 | $-2.40 | $-2.97 | $-3.73 | $-5.84 | $-7.17 | $-9.76 | $-6.27 | $-6.97 | $-5.61 |
| Low Forecast | $0.12 | $0.12 | $0.11 | $0.05 | $0.04 | $0.04 | $0.03 | $-0.04 | $-0.04 | $-0.09 | $-0.22 | $-0.18 | $-0.19 | $-0.14 | $-0.86 | $-0.54 | $-0.42 | $-2.69 | $-0.89 | $-1.32 | $-2.82 | $-2.58 | $-3.19 | $-4.01 | $-6.28 | $-7.70 | $-10.49 | $-6.74 | $-7.48 | $-6.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.08% | 0.20% | 2.26% | 1.73% | 0.15% | 0.02% | 0.17% | 0.14% | 0.23% | 0.09% | 2.45% | 0.19% | 2.43% |
According to undefined Wall Street analysts, Aurora Cannabis's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ACB previous annual EPS of $NaN (undefined).
ACB Forecast FAQ
Is Aurora Cannabis a good buy?
No, according to 7 Wall Street analysts, Aurora Cannabis (ACB) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 28.57% of ACB's total ratings.
What is ACB's price target?
Aurora Cannabis (ACB) average price target is $5.92 with a range of $1 to $8.75, implying a 2.07% from its last price of $5.8. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Aurora Cannabis stock go up soon?
According to Wall Street analysts' prediction for ACB stock, the company can go up by 2.07% (from the last price of $5.8 to the average price target of $5.92), up by 50.92% based on the highest stock price target, and down by -82.76% based on the lowest stock price target.
Can Aurora Cannabis stock reach $9?
ACB's average twelve months analyst stock price target of $5.92 does not support the claim that Aurora Cannabis can reach $9 in the near future.
What are Aurora Cannabis's analysts' financial forecasts?
Aurora Cannabis's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $226.02M (high $233.12M, low $218.9M), average EBITDA is $-137M (high $-133M, low $-141M), average net income is $-12.985M (high $-6.839M, low $-18.808M), average SG&A $194.07M (high $200.15M, low $187.95M), and average EPS is $-0.274 (high $-0.144, low $-0.397). ACB's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $227.01M (high $234.88M, low $219.09M), average EBITDA is $-138M (high $-133M, low $-143M), average net income is $7.64M (high $7.98M, low $7.29M), average SG&A $194.91M (high $201.67M, low $188.11M), and average EPS is $0.161 (high $0.168, low $0.154).
Did the ACB's actual financial results beat the analysts' financial forecasts?
Based on Aurora Cannabis's last annual report (Jun 2022), the company's revenue was $221.34M, beating the average analysts forecast of $195.52M by 13.20%. Apple's EBITDA was $-143M, missing the average prediction of $-19.254B by -99.26%. The company's net income was $-1.718B, missing the average estimation of $-20.433B by -91.59%. Apple's SG&A was $188.99M, beating the average forecast of $167.88M by 12.58%. Lastly, the company's EPS was $-7.99, missing the average prediction of $-9.561 by -16.44%. In terms of the last quarterly report (Dec 2022), Aurora Cannabis's revenue was $61.68M, beating the average analysts' forecast of $47.95M by 28.63%. The company's EBITDA was $-53.868M, beating the average prediction of $-29.092M by 85.17%. Aurora Cannabis's net income was $-67.183M, missing the average estimation of $-122M by -45.03%. The company's SG&A was $44.57M, beating the average forecast of $41.17M by 8.25%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-2.577 by -91.85%